FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anu Jalanko

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Anatomy

Physiology

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Enzo Scifo; Agnieszka Szwajda; Jaana Tyynelä; Kristiina Uusi-Rauva; Marc H Baumann; Michał Dadlez; Janusz Dębski; Anne-Claude Gingras; Anu Jalanko; Tapio Kesti; Maciej Lalowski
Drafting the CLN3 Protein Interactome in SH-SY5Y Human Neuroblastoma Cells: A Label-free Quantitative Proteomics Approach.
Tomas Blom; Jonathan D Cooper; Matti Jauhiainen; Aija Kyttälä; Mia-Lisa Schmiedt; Jarkko Soronen; Jaana Tyynelä; Andrew M Wong; Anu Jalanko
Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice.
Mervi Kuronen; Anna-Elina Lehesjoki; Jonathan D Cooper; Anu Jalanko; Outi Kopra
Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anu Jalanko (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Enzo Scifo; Agnieszka Szwajda; Jaana Tyynelä; Kristiina Uusi-Rauva; Marc H Baumann; Michał Dadlez; Janusz Dębski; Anne-Claude Gingras; Anu Jalanko; Tapio Kesti; Maciej Lalowski
Drafting the CLN3 Protein Interactome in SH-SY5Y Human Neuroblastoma Cells: A Label-free Quantitative Proteomics Approach.
Journal of proteome research 2013;12(5):2101-15.
2013: Tomas Blom; Jonathan D Cooper; Matti Jauhiainen; Aija Kyttälä; Mia-Lisa Schmiedt; Jarkko Soronen; Jaana Tyynelä; Andrew M Wong; Anu Jalanko
Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice.
Disease models & mechanisms 2013;6(2):342-57.
2012: Mervi Kuronen; Anna-Elina Lehesjoki; Jonathan D Cooper; Anu Jalanko; Outi Kopra
Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice.
Neurobiology of disease 2012;47(3):444-57.
2012: Kristiina Uusi-Rauva; Rik van der Kant; Jouni Vesa; Aija Kyttälä; Jacques Neefjes; Vesa M Olkkonen; Kimmo Tanhuanpää; Anu Jalanko
Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments.
Cellular and molecular life sciences : CMLS 2012;69(12):2075-89.
2012: Mia-Lisa Schmiedt; Carina von Schantz-Fant; Andrew Wong; Matti Jauhiainen; Outi Kopra; Mervi Kuronen; Tomas Blom; Tomas Blom; Jonathan D Cooper; Elina Ikonen; Anu Jalanko
Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism.
Neurobiology of disease 2012;46(1):19-29.
2010: Anniina Raitila; Heli J Lehtonen; Johanna Arola; Elina Heliövaara; Manuel Ahlsten; Marianthi Georgitsi; Anu Jalanko; Anders Paetau; Lauri A Aaltonen; Auli Karhu
Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression.
The American journal of pathology 2010;177(4):1969-76.
2010: Mia-Lisa Schmiedt; Carlos Bessa; Claudia Heine; Maria Gil Ribeiro; Anu Jalanko; Aija Kyttälä
The neuronal ceroid lipofuscinosis protein CLN5: new insights into cellular maturation, transport, and consequences of mutations.
Human mutation 2010;31(3):356-65.
2009: Anu Jalanko; Thomas Braulke
Neuronal ceroid lipofuscinoses.
Biochimica et biophysica acta 2009;1793(4):697-709.
2009: Annina Lyly; Carina von Schantz; Claudia Heine; Mia-Lisa Schmiedt; Tessa Sipilä; Anu Jalanko; Aija Kyttälä
Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins.
BMC cell biology 2009;10():83.
2008: Kristiina Uusi-Rauva; Kaisu Luiro; Kimmo Tanhuanpää; Outi Kopra; Pablo Martín-Vasallo; Aija Kyttälä; Anu Jalanko
Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
Experimental cell research 2008;314(15):2895-905.
2008: Annina Lyly; Sanna K Marjavaara; Aija Kyttälä; Kristiina Uusi-Rauva; Kaisu Luiro; Outi Kopra; Laurent O Martinez; Kimmo Tanhuanpää; Nisse Kalkkinen; Anu Suomalainen; Matti Jauhiainen; Anu Jalanko
Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism.
Human molecular genetics 2008;17(10):1406-17.
2008: Carina von Schantz; Juha Saharinen; Outi Kopra; Jonathan D Cooper; Massimiliano Gentile; Iiris Hovatta; Leena Peltonen; Anu Jalanko
Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases.
BMC genomics 2008;9():146.
2007: Laura Ahtiainen; Julia Kolikova; Aino-Liisa Mutka; Kaisu Luiro; Massimiliano Gentile; Elina Ikonen; Leonard Khiroug; Anu Jalanko; Outi Kopra
Palmitoyl protein thioesterase 1 (Ppt1)-deficient mouse neurons show alterations in cholesterol metabolism and calcium homeostasis prior to synaptic dysfunction.
Neurobiology of disease 2007;28(1):52-64.
2007: Heli J Lehtonen; Sanna K Ylisaukko-oja; Maija Kiuru; Auli Karhu; Rainer Lehtonen; Sakari Vanharanta; Anu Jalanko; Lauri A Aaltonen; Virpi Launonen
Stress-induced expression of a novel variant of human fumarate hydratase (FH).
Gene expression 2007;14(2):59-69.
2007: Annina Lyly; Carina von Schantz; Tarja Salonen; Outi Kopra; Janna Saarela; Matti Jauhiainen; Aija Kyttälä; Anu Jalanko
Glycosylation, transport, and complex formation of palmitoyl protein thioesterase 1 (PPT1)--distinct characteristics in neurons.
BMC cell biology 2007;8():22.
2006: Anu Jalanko; Jaana Tyynelä; Leena Peltonen
From genes to systems: new global strategies for the characterization of NCL biology.
Biochimica et biophysica acta 2006;1762(10):934-44.
2006: Kaisu Luiro; Outi Kopra; Tomas Blom; Massimiliano Gentile; Hannah M Mitchison; Iiris Hovatta; Kid Törnquist; Anu Jalanko
Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments.
Journal of neuroscience research 2006;84(5):1124-38.
2006: Salli Virta; Juhani Rapola; Anu Jalanko; Minna Laine
Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse.
The journal of gene medicine 2006;8(6):699-706.
2006: Laura Ahtiainen; Kaisu Luiro; Maria Kauppi; Jaana Tyynelä; Outi Kopra; Anu Jalanko
Palmitoyl protein thioesterase 1 (PPT1) deficiency causes endocytic defects connected to abnormal saposin processing.
Experimental cell research 2006;312(9):1540-53.
2005: Henna Tyynismaa; Katja Peltola Mjosund; Sjoerd Wanrooij; Ilse Lappalainen; Emil Ylikallio; Anu Jalanko; Johannes N Spelbrink; Anders Paetau; Anu Suomalainen
Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(49):17687-92.
2005: Aija Kyttälä; Kristiina Yliannala; Peter Schu; Anu Jalanko; J Paul Luzio
AP-1 and AP-3 facilitate lysosomal targeting of Batten disease protein CLN3 via its dileucine motif.
The Journal of biological chemistry 2005;280(11):10277-83.
2005: Anu Jalanko; Jouni Vesa; Tuula Manninen; Carina von Schantz; Helena Minye; Anna-Liisa Fabritius; Tarja Salonen; Juhani Rapola; Massimiliano Gentile; Outi Kopra; Leena Peltonen
Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons.
Neurobiology of disease 2005;18(1):226-41.
2004: Henna Tyynismaa; Hiroshi Sembongi; Monika Bokori-Brown; Caroline Granycome; Neil Ashley; Joanna Poulton; Anu Jalanko; Johannes N Spelbrink; Ian J Holt; Anu Suomalainen
Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number.
Human molecular genetics 2004;13(24):3219-27.
2004: M Laine; Laura Ahtiainen; Juhani Rapola; J Richter; Anu Jalanko
Bone marrow transplantation in young aspartylglucosaminuria mice: improved clearance of lysosomal storage in brain by using wild type as compared to heterozygote donors.
Bone marrow transplantation 2004;34(11):1001-3.
2004: Kaisu Luiro; Kristiina Yliannala; Laura Ahtiainen; Heidi Maunu; Irma Järvelä; Aija Kyttälä; Anu Jalanko
Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway.
Human molecular genetics 2004;13(23):3017-27.
2004: Outi Kopra; Jouni Vesa; Carina von Schantz; Tuula Manninen; Helena Minye; Anna-Liisa Fabritius; Juhani Rapola; Otto P van Diggelen; Janna Saarela; Anu Jalanko; Leena Peltonen
A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging.
Human molecular genetics 2004;13(23):2893-906.
2004: Janna Saarela; Carina von Schantz; Leena Peltonen; Anu Jalanko
A novel aspartylglucosaminuria mutation affects translocation of aspartylglucosaminidase.
Human mutation 2004;24(4):350-1.
2004: Liina Lonka; Tarja Salonen; Eija Siintola; Outi Kopra; Anna-Elina Lehesjoki; Anu Jalanko
Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells.
Journal of neuroscience research 2004;76(6):862-71.
2004: Ville Holmberg; Anu Jalanko; Juha Isosomppi; Anna-Liisa Fabritius; Leena Peltonen; Outi Kopra
The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain.
Neurobiology of disease 2004;16(1):29-40.
2004: Nina Aula; Outi Kopra; Anu Jalanko; Leena Peltonen
Sialin expression in the CNS implicates extralysosomal function in neurons.
Neurobiology of disease 2004;15(2):251-61.
2004: Janna Saarela; Carita Oinonen; Anu Jalanko; Juha Rouvinen; Leena Peltonen
Autoproteolytic activation of human aspartylglucosaminidase.
The Biochemical journal 2004;378(Pt 2):363-71.
2003: Salli Harkke; Minna Laine; Anu Jalanko
Aspartylglucosaminidase (AGA) is efficiently produced and endocytosed by glial cells: implication for the therapy of a lysosomal storage disorder.
The journal of gene medicine 2003;5(6):472-82.
2003: Laura Ahtiainen; Otto P van Diggelen; Anu Jalanko; Outi Kopra
Palmitoyl protein thioesterase 1 is targeted to the axons in neurons.
The Journal of comparative neurology 2003;455(3):368-77.
2002: Jonas Bondestam; Noora Kaivo-oja; Janne P Kallio; Nigel Groome; Christel Hydén-Granskog; Makiko Fujii; Aristidis Moustakas; Anu Jalanko; Peter ten Dijke; Olli Ritvos
Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
Molecular and cellular endocrinology 2002;195(1-2):79-88.
2002: Nina Aula; Anu Jalanko; Pertti Aula; Leena Peltonen
Unraveling the molecular pathogenesis of free sialic acid storage disorders: altered targeting of mutant sialin.
Molecular genetics and metabolism 2002;77(1-2):99-107.
2002: Jouni Vesa; Mark Chin; Kathrin Oelgeschläger; Juha Isosomppi; Esteban C DellAngelica; Anu Jalanko; Leena Peltonen
Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3.
Molecular biology of the cell 2002;13(7):2410-20.
2002: Juha Isosomppi; Jouni Vesa; Anu Jalanko; Leena Peltonen
Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein.
Human molecular genetics 2002;11(8):885-91.
2001: Kaisu Luiro; Outi Kopra; M Lehtovirta; Anu Jalanko
CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
Human molecular genetics 2001;10(19):2123-31.
2001: Outi Kopra; O Heinonen-Kopra; Jouni Vesa; Anu Jalanko
Neuronal trafficking of palmitoyl protein thioesterase provides an excellent model to study the effects of different mutations which cause infantile neuronal ceroid lipofuscinocis.
Molecular and cellular neurosciences 2001;18(2):131-40.
2001: Janna Saarela; M Laine; Carita Oinonen; C von Schantz; Anu Jalanko; Juha Rouvinen; Leena Peltonen
Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations.
Human molecular genetics 2001;10(9):983-95.
2001: M Lehtovirta; Aija Kyttälä; E L Eskelinen; M Hess; Outi Kopra; Anu Jalanko
Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL).
Human molecular genetics 2001;10(1):69-75.
2000: Outi Kopra; Tarja Salonen; Anu Jalanko; Leena Peltonen; A Copp
CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain.
The Journal of comparative neurology 2000;426(3):406-12.
2000: Liina Lonka; Aija Kyttälä; Sirpa Ranta; Anu Jalanko; Anna-Elina Lehesjoki
The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum.
Human molecular genetics 2000;9(11):1691-7.
2000: Outi Kopra; Aija Kyttälä; E Lehmus; Tiina Paunio; Leena Peltonen; Anu Jalanko
Expression of palmitoyl protein thioesterase in neurons.
Molecular genetics and metabolism 2000;69(2):123-9.
2000: Tarja Salonen; Irma Järvelä; Leena Peltonen; Anu Jalanko
Detection of eight novel palmitoyl protein thioesterase (PPT) mutations underlying infantile neuronal ceroid lipofuscinosis (INCL;CLN1).
Human mutation 2000;15(3):273-9.
1999: Juha Isosomppi; Outi Kopra; Jukka O Hiltunen; Nicholas D E Greene; Jouni Vesa; A Uusitalo; Hannah M Mitchison; Mart Saarma; Anu Jalanko; Leena Peltonen
Developmental expression of palmitoyl protein thioesterase in normal mice.
Brain research. Developmental brain research 1999;118(1-2):1-11.
1999: M Laine; J Richter; C Fahlman; Juhani Rapola; Martin Renlund; Leena Peltonen; S Karlsson; Anu Jalanko
Correction of peripheral lysosomal accumulation in mice with aspartylglucosaminuria by bone marrow transplantation.
Experimental hematology 1999;27(9):1467-74.
1999: A Uusitalo; K Tenhunen; Outi Kopra; Jukka O Hiltunen; M Saarma; Matti Haltia; Anu Jalanko; Leena Peltonen
Toward understanding the neuronal pathogenesis of aspartylglucosaminuria: expression of aspartylglucosaminidase in brain during development.
Molecular genetics and metabolism 1999;67(4):294-307.
1999: Hannele Kangas; Ismo Ulmanen; Tiina Paunio; D J Kwiatkowski; M Lehtovirta; Anu Jalanko; Leena Peltonen
Functional consequences of amyloidosis mutation for gelsolin polypeptide -- analysis of gelsolin-actin interaction and gelsolin processing in gelsolin knock-out fibroblasts.
FEBS letters 1999;454(3):233-9.
1999: Irma Järvelä; M Lehtovirta; R Tikkanen; Aija Kyttälä; Anu Jalanko
Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
Human molecular genetics 1999;8(6):1091-8.
1999: Leena Peltonen; Anu Jalanko; Teppo Varilo
Molecular genetics of the Finnish disease heritage.
Human molecular genetics 1999;8(10):1913-23.
1998: K Tenhunen; A Uusitalo; Taina Autti; Raimo Joensuu; M Kettunen; Risto A Kauppinen; S Ikonen; Mary E LaMarca; Matti Haltia; Edward I Ginns; Anu Jalanko; Leena Peltonen
Monitoring the CNS pathology in aspartylglucosaminuria mice.
Journal of neuropathology and experimental neurology 1998;57(12):1154-63.
1998: M Peltola; Aija Kyttälä; Outi Kopra; Juhani Rapola; Tiina Paunio; F Revah; Leena Peltonen; Anu Jalanko
Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouse.
Gene therapy 1998;5(10):1314-21.
1998: Aija Kyttälä; Outi Kopra; Leena Peltonen; Anu Jalanko
Expression and endocytosis of lysosomal aspartylglucosaminidase in mouse primary neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(19):7750-6.
1998: Janna Saarela; M Laine; R Tikkanen; Carita Oinonen; Anu Jalanko; Juha Rouvinen; Leena Peltonen
Activation and oligomerization of aspartylglucosaminidase.
The Journal of biological chemistry 1998;273(39):25320-8.
1998: Outi Kopra; E Hellsten; N Horelli-Kuitunen; Leena Peltonen; Anu Jalanko
Mouse palmitoyl protein thioesterase: gene structure and expression of cDNA.
Genome research 1998;8(7):724-30.
1998: Anu Jalanko; K Tenhunen; CE McKinney; Mary E LaMarca; Juhani Rapola; Taina Autti; Raimo Joensuu; Tuula Manninen; I Sipilä; S Ikonen; P Riekkinen; Edward I Ginns; Leena Peltonen
Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients.
Human molecular genetics 1998;7(2):265-72.
1998: Irma Järvelä; Markku Sainio; T Rantamäki; V M Olkkonen; Olli Carpén; Leena Peltonen; Anu Jalanko
Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
Human molecular genetics 1998;7(1):85-90.
1997: H Mikkola; László Muszbek; Gizella Haramura; Eija Hämäläinen; Anu Jalanko; Aarno Palotie
Molecular mechanisms of mutations in factor XIII A-subunit deficiency: in vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins.
Thrombosis and haemostasis 1997;77(6):1068-72.
1997: A Uusitalo; K Tenhunen; J Tenhunen; S Matikainen; Leena Peltonen; Anu Jalanko
Expression and regulation of the human and mouse aspartylglucosaminidase gene.
The Journal of biological chemistry 1997;272(14):9524-30.
1997: E Hellsten; Jouni Vesa; Anu Jalanko; Leena Peltonen
From locus to cellular disturbances: positional cloning of the infantile neuronal ceroid lipofuscinosis gene.
Neuropediatrics 1997;28(1):9-11.
1996: E Hellsten; Jouni Vesa; V M Olkkonen; Anu Jalanko; Leena Peltonen
Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis.
The EMBO journal 1996;15(19):5240-5.
1996: Hannele Kangas; Tiina Paunio; N Kalkkinen; Anu Jalanko; Leena Peltonen
In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis.
Human molecular genetics 1996;5(9):1237-43.
1996: A Riikonen; Juha Rouvinen; R Tikkanen; Ilkka Julkunen; Leena Peltonen; Anu Jalanko
Primary folding of aspartylglucosaminidase. Significance of disulfide bridges and evidence of early multimerization.
The Journal of biological chemistry 1996;271(35):21340-4.
1996: M Peltola; R Tikkanen; Leena Peltonen; Anu Jalanko
Ser72Pro active-site disease mutation in human lysosomal aspartylglucosaminidase: abnormal intracellular processing and evidence for extracellular activation.
Human molecular genetics 1996;5(6):737-43.
1996: Anu Jalanko; M Ranki; L Palotie
[Diseases and gene defects].
Duodecim; lääketieteellinen aikakauskirja 1996;112(4):307-14.
1995: K Tenhunen; M Laan; T Manninen; Aarno Palotie; Leena Peltonen; Anu Jalanko
Molecular cloning, chromosomal assignment, and expression of the mouse aspartylglucosaminidase gene.
Genomics 1995;30(2):244-50.
1995: N Enomaa; O Danos; Leena Peltonen; Anu Jalanko
Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transfer.
Human gene therapy 1995;6(6):723-31.
1995: A Riikonen; R Tikkanen; Anu Jalanko; Leena Peltonen
Immediate interaction between the nascent subunits and two conserved amino acids Trp34 and Thr206 are needed for the catalytic activity of aspartylglucosaminidase.
The Journal of biological chemistry 1995;270(9):4903-7.
1995: Anu Jalanko; T Manninen; Leena Peltonen
Deletion of the C-terminal end of aspartylglucosaminidase resulting in a lysosomal accumulation disease: evidence for a unique genomic rearrangement.
Human molecular genetics 1995;4(3):435-41.
1995: A Isoniemi; Marja Hietala; Pertti Aula; Anu Jalanko; Leena Peltonen
Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene.
Human mutation 1995;5(4):318-26.
1994: M Peltola; D Chiatayat; Leena Peltonen; Anu Jalanko
Characterization of a point mutation in aspartylglucosaminidase gene: evidence for a readthrough of a translational stop codon.
Human molecular genetics 1994;3(12):2237-42.
1994: Maurizia Rossana Brunetto; A Randone; M Ranki; Anu Jalanko; P Piantino; M Giarin; G Capra; P L Calvo; Filippo Oliveri; Ferruccio Bonino
Quantitative analysis of wild-type and HBeAg minus hepatitis B viruses by a sequence-dependent primer extension assay.
Journal of medical virology 1994;43(3):310-5.
1994: A Riikonen; E Ikonen; R Sormunen; V P Lehto; Leena Peltonen; Anu Jalanko
Dissection of the molecular consequences of a double mutation causing a human lysosomal disease.
DNA and cell biology 1994;13(3):257-64.
1993: L Harju; T Weber; L Alexandrova; Mark Lukin; M Ranki; Anu Jalanko
Colorimetric solid-phase minisequencing assay illustrated by detection of alpha 1-antitrypsin Z mutation.
Clinical chemistry 1993;39(11 Pt 1):2282-7.
1993: J Tenhunen; M Salminen; Anu Jalanko; S Ukkonen; Ismo Ulmanen
Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme.
DNA and cell biology 1993;12(3):253-63.
1992: Carola Gabriella Tilgmann; K Melen; K Lundström; Anu Jalanko; Ilkka Julkunen; Nisse Kalkkinen; Ismo Ulmanen
Expression of recombinant soluble and membrane-bound catechol O-methyltransferase in eukaryotic cells and identification of the respective enzymes in rat brain.
European journal of biochemistry / FEBS 1992;207(2):813-21.
1992: Anu Jalanko; J Kere; E Savilahti; M Schwartz; A C Syvänen; M Ranki; Hans Söderlund
Screening for defined cystic fibrosis mutations by solid-phase minisequencing.
Clinical chemistry 1992;38(1):39-43.
1991: K Lundström; M Salminen; Anu Jalanko; R Savolainen; Ismo Ulmanen
Cloning and characterization of human placental catechol-O-methyltransferase cDNA.
DNA and cell biology 1991;10(3):181-9.
1989: Anu Jalanko; A Kallio; M Salminen; Ismo Ulmanen
Efficient synthesis of influenza virus hemagglutinin in mammalian cells with an extrachromosomal Epstein-Barr virus vector.
Gene 1989;78(2):287-96.
1988: Anu Jalanko; A Kallio; M Ruohonen-Lehto; Hans Söderlund; Ismo Ulmanen
An EBV-based mammalian cell expression vector for efficient expression of cloned coding sequences.
Biochimica et biophysica acta 1988;949(2):206-12.
1988: Anu Jalanko; A Kallio; Ismo Ulmanen
Comparison of mammalian cell expression vectors with and without an EBV-replicon.
Archives of virology 1988;103(3-4):157-66.
1985: Anu Jalanko; Hans Söderlund
The repeated regions of Semliki Forest virus defective-inferfering RNA interferes with the encapsidation process of the standard virus.
Virology 1985;141(2):257-66.